Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Risk Assessment

This article was originally published in SRA

Executive Summary

UK public health body highlights risks of asymptomatic CT scanning

UK public health body highlights risks of asymptomatic CT scanning

The UK Health Protection Agency has expressed its support for recommendations that the commercial use of X-ray computed tomography scanning on asymptomatic individuals be stopped because of potential radiation risks1.

A report by the Committee on Medical Aspects of Radiation in the Environment (Comare), an independent expert government advisory committee, says that the regulation of CT scanning by private health services should be reviewed and recommends that patients should receive information regarding dose and risk of the CT scan, as well as rates of false negative and false positive results2.

Medical exposures to radiation comprise about 14% of the average annual dose of radiation to the UK population, Comare notes. While it is recognised that technical innovations could lead to greater diagnostic accuracy, the committee warns that greater accuracy does not outweigh the risks of greater radiation doses as a result of scanning.

Comare recommends that commercial services offering whole body CT scanning to people who have no symptoms of illness should stop doing so; individuals displaying symptoms and requesting a CT scan from a commercial service should not be scanned and should be referred back to their general practitioner. The committee also advises that CT should not be used for assessing spinal conditions, body fat and osteoporosis in asymptomatic individuals. Scanning for lung conditions was also found to be of no benefit. However, the committee found that CT scanning for cardiovascular risk is beneficial, as is CT colonography.

The committee says that commercial CT scan services should have well-developed and confidential mechanisms for integrating examination results into an established care pathway and ensuring that data is consistent with National Health Service IT programme formats.

References

1. HPA press release, 19 December 2007, www.hpa.org.uk/hpa/news/articles/press_releases/2007/071219_CT_scanning.htm

2. Committee on Medical Aspects of Radiation in the Environment, Twelfth Report, www.comare.org.uk/documents/COMARE12thReport.pdf

Latest Headlines
See All
UsernamePublicRestriction

Register

PS113743

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel